For last several decades of the 20th century, all histological variants of NSCLC were generally treated identically. In the last decade, it has become apparent that different variants of malignant tumors generally exhibit diverse genetic, biological, and clinical properties, including response to treatment. As patients with uncommon lung tumor variants, including tumors composed of mixtures of histological subtypes, tend to be excluded from clinical trials, the most efficacious treatment regimen(s) for<unk>  squamous<unk>  carcinoma remain unknown. In general, these variants appear to be treated according to standard protocols in place for squamous<unk>  carcinoma.
Basaloid squamous cell lung carcinoma
Salivary gland–like carcinoma of the lung
Adenosquamous lung carcinoma
Epithelial-myoepithelial carcinoma of the lung
Sarcomatoid carcinoma of the lung
Basaloid large cell carcinoma of the lung
Mucinous cystadenocarcinoma of the lung
Giant-cell carcinoma of the lung